What happened? Smith & Nephew (NYSE: SNN) will be acquiring Osiris Therapeutics (NASDAQ: OSIR) for $660M. The investment, announced today, potentially repositions Smith & Nephew within the CTP (cellular and tissue-based products) space. If the deal goes through, it will be Smith & Nephew’s most significant M&A deal within that space since the acquisition of … Read More
Wound Care Products
Debrief: Association for The Advancement of Wound Care (AAWC) 2019 Pressure Ulcer Summit [Video]
The Association for The Advancement of Wound Care (AAWC) has just wrapped up its pressure ulcer summit in Atlanta, Georgia. Highlights included: The patient journey International participation and sharing of approaches (Switzerland, UK, Ireland, Mexico, and others) A pressure ulcer workshop Technical and scientific discussions Challenges and opportunities across the continuum of care Advocacy for … Read More
Investing in Advanced Wound Care? Avoid These 3 Costly Mistakes
We are frequently tapped by analysts, fund managers, investment banks, and other financial and investment professionals–from small independent funds through the largest global institutions. At the same time, our engagements are also filled by biotech, medtech, life sciences, and digital health executives, as well as provider and clinic networks, payers, hospitals, IDNs, and other healthcare … Read More
Confused by Recent Wound Care Digital Health Developments and Their Implications?
In many ways, the pace of innovation in advanced wound care can feel slow compared to other areas of medtech. As a result, many from across the spectrum are understandably confused by recent digital wound care news and developments. Relative to the rest of the sector, this segment is evolving at light speed. Many wound … Read More
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business Outlook
What We’ve Been up to in 2018 Q3 – Q4 and What It Means for the Global Wound Care Business Outlook A tour around the wound care world The past few months of 2018 have been quite packed and exciting for us at Diligence Wound Care Global. We wanted to share some of what we’ve … Read More
Urgo’s M&A of SteadMed: Here’s What You Need to Know
There has just been another significant wound care acquisition. French MNC Urgo Medical just announced the M&A of Texas-based SteadMed Medical. The resulting entity will be known as Urgo Medical North America. If you’re an advanced wound care stakeholder inside North America, you may be wondering, “Who is Urgo Medical?” If you’re an advanced wound … Read More
Were You Caught off Guard by the Healogics iSupply Announcement This Week?
What happened? The latest wound care development is the new Healogics iSupply program, announced this week. Highlights of the initiative include: Special pricing on many/most categories of wound care and related regenerative medicine products. Leverage of outcomes and utilization management data. Quarterly product/supply reporting initiatives. Potential for future evolution based on the Healogics database and … Read More
Why Mölnlycke’s Acquisition of SastoMed Is a Big Deal
What happened? Today (2018.07.02), Mölnlycke Health Care announced its acquisition of SastoMed GmbH. Mölnlycke is of course known in the industry as a top global wound care (also wound prevention and surgical) product brand, particularly in Europe and the United States. SastoMed, a much smaller German firm, was a subsidiary of SanderStrothmann GmbH, a company which assesses, formulates, … Read More
Wound Care in Malaysia and The Emerging Markets: Interview w/ Dr. Mogan Naidu (1 of 2) [Video]
Do you feel confident in your command of global wound care? This video may cause you to reconsider… Much of our time at Diligence Wound Care Global is spent with wound care product and services CEOs, CMOs, CCOs, VPs, directors, and managers for global strategy, busdev, marketing, finance, R&D, and other functions related to commercial … Read More
What the Recent Healogics Developments Can Teach Us About the Future of Wound Care
The situation Last week (15 Nov 2017), David Bassin (Healogics’ former CFO), was appointed as the company’s new CEO. As the world’s biggest wound management firm and provider of wound services, Healogics has both a massive network and a huge volume of wound care and outcomes data. Understandably, healthcare executives, analysts, and investors watching this space have … Read More